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INTRODUCTION
Mesenteric panniculitis is a rare disorder characterized 
by a tumor-like expansion of the mesentery due to variable 
degrees of fat necrosis, chronic inflammation and fibrosis. Its 
pathophysiology remains unclear despite the description of 
associations with inflammatory disorders or malignancies, 
especially lymphomas.1 The disease remains asymptomatic 
in 30-50% of cases, and the most common clinical 
presentations are abdominal pain, palpable abdominal mass 
or intestinal obstruction.1,2 Most patients present a benign, 
slowly progressive course, and the outcome of the disease is 
usually favorable.1,2 Nevertheless, in about 20% of patients, 
mesenteric panniculitis is associated with significant 
morbidity and a chronic debilitating course.3
We report a case of this poorly known entity, which 
presented as a systemic disease with severe constitutional 
manifestations and rapid deterioration of the general 
condition of the patient, which made diagnosis difficult. 
CASE DESCRIPTION
A 36-year-old previously healthy man was admitted 
to our institution with daily fever (up to 39.3°C), chills, 
significant weight loss (more than 10% of his normal weight) 
and severe impairment of his general condition lasting for 
six weeks before admission. He denied abdominal pain 
and gastrointestinal symptoms. Physical examination was 
unremarkable except for a hard and slightly painful mass in 
the left upper abdomen. Laboratory investigations showed 
hemoglobin levels at 10.2 g/dL, a white blood cell count 
of 27,300/mm3 with a shift to the left, a platelet cell count 
of 640,000/mm3, an erythrocyte sedimentation rate (ESR) 
of 100 mm/1h, C-reactive protein levels at 192 mg/L and 
serum albumin levels of 2.2 g/dL. Bilirubin levels, hepatic 
and pancreatic enzyme levels and renal function tests were 
normal. Blood cultures, the anti-HIV test and the tuberculin 
skin test (PPD) were negative, and the chest x-ray showed 
no abnormalities. Abdominal CT scan revealed a soft-
tissue mass in the left upper abdomen, as well as increased 
attenuation of mesenteric and perinephric fat on the left. 
During hospitalization, the patient continued to have 
daily fever and significant weight loss. Repeated physical 
examination revealed marked variation of the sensitivity, 
location and size of the abdominal mass. Laparoscopy identified 
a solid tumor measuring approximately 10 cm in diameter 
located in the mesentery, and a biopsy of this lesion showed 
nonspecific inflammatory changes. Since a diagnosis was not 
achieved, the patient was submitted to exploratory laparotomy, 
which disclosed a hard mass involving the transverse mesocolon 
at the level of the splenic flexure adhered to the bowel loops. 
Light grey necrotic tissue was observed upon the sectioning 
of the adhesions. A biopsy of the mass was performed. 
Histopathological examination of this material showed well-
vascularized fibroadipose tissue with areas of adiponecrosis and 
nests of foamy macrophages, areas of recent hemorrhage, foci 
of mononuclear cell inflammatory infiltrate and proliferation of 
bundle-forming fibroblasts (Figure 1). All tests and cultures for 
fungi and mycobacteria were negative.
Due to the progressive worsening of the patient, we 
started prednisone administration (60 mg/day). The fever 
disappeared within a few days, and the patient experienced 
a steady progressive improvement. A regression of the 
abdominal mass was also observed. After two weeks, the 
corticosteroid was gradually tapered until its complete 
discontinuation in five months. Blood cell counts, ESR, 
C-reactive protein and albumin returned to the normal 
values within several weeks. An abdominal CT performed 
six months after the beginning of the treatment showed a 
complete disappearance of the abnormalities. Two years 
later, the patient remains in good health with no recurrence.
DISCUSSION
Mesenteric panniculitis is a rare disorder of unknown 
etiology that is likely underdiagnosed. Some associated 
conditions have already been reported: malignancies 
(lymphoma and carcinoma), autoimmunity, infection, trauma 
and a history of previous surgery. However, definitive causal 
relationships have never been confirmed.1,3 
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The condition predominantly occurs in males and is more 
frequent between the 6th and 7th decades of life.3 A wide 
variety of gastrointestinal and systemic manifestations have 
been associated with this disorder; however, the most common 
presentations are abdominal pain, bloating and distension, 
diarrhea, abdominal mass and intestinal obstruction.1-5 Other 
reported symptoms include weight loss, constipation, anorexia 
and fever.2,3 Presentations such as fever of unknown origin 
and protein-losing enteropathy have also been described. 
Laboratory parameters are frequently normal; however, an 
increased erythrocyte sedimentation rate has been noted.3 
The present case showed some peculiarities that made 
its diagnosis difficult. Our patient was younger than most 
of the reported cases and his clinical picture, dominated by 
severe systemic symptoms and rapidly progressive clinical 
deterioration, along with the presence of significant leukocytosis 
and elevated levels of the markers of acute phase response, 
suggested a systemic disease and made the diagnosis difficult. 
Another interesting characteristic of the present case was the 
marked variation in the characteristics of the abdominal mass 
upon physical examination performed on different occasions. 
Abdominal CT is currently being proposed as an effective 
method for diagnostic evaluation. Two CT findings are 
considered somewhat specific for this disorder: a “fat ring 
sign” that reflects the preservation of fat around the mesenteric 
vessels, and the presence of a “tumoral pseudocapsule,” 
which is detected in 50% of patients.6 In a recently published 
series of 92 patients, the main CT findings were a single soft-
tissue mass in the root of the mesentery that often contained 
calcification (61% of cases) and a subtly increased density of 
the mesenteric fat, with or without discrete soft-tissue masses, 
suggesting mild mesenteric fibrosis or inflammation (34% of 
cases).3 In the present case, the CT findings contributed little 
to the diagnosis due to their lack of specificity.
The definite diagnosis of mesenteric panniculitis is established 
by biopsy. Variable combinations of foci of fat degeneration 
and necrosis, a nonspecific and predominantly lymphocytic 
inflammatory infiltrate and fibrosis have been reported.2,3 
Based on the predominant histological findings, the disease has 
been called mesenteric lipodystrophy, mesenteric panniculitis 
or sclerosing mesenteritis, according to the predominance 
of adiponecrosis, inflammation or fibrosis, respectively. 
Some evidence suggests that these three morphological 
lesions represent a single clinical entity.2 In the present case, 
inflammation was the most prominent feature, although 
adiponecrosis and areas of fibrosis were observed (Figure 1).
The differential diagnosis of mesenteric panniculitis is 
broad and includes all disorders that can affect the mesentery. 
The most common are lymphoma, well-differentiated 
liposarcoma, peritoneal carcinomatosis, carcinoid tumor, 
retroperitoneal fibrosis, lipoma, mesenteric desmoid 
tumor, mesenteric inflammatory pseudotumor, mesenteric 
fibromatosis and mesenteric edema.1,7 
The course of mesenteric panniculitis is favorable in 
most cases,1,2 because the disease usually progresses slowly 
and subsides spontaneously. Nevertheless, in about 20% of 
patients, it is associated with significant morbidity and a 
chronic debilitating course.3
In our patient, the severity and rapid progression of 
the symptoms led us to prescribe prednisone, which had 
an excellent response. Other authors have also reported a 
beneficial effect of corticosteroid therapy.3,5 Other empirically 
proposed therapy options include tamoxifen, azathioprine, 
cyclophosphamide, oral progesterone and thalidomide. 
Surgical resection is generally not recommended and has no 
beneficial effects, except in cases of intestinal obstruction 
and other complications, such as ischemia.
In conclusion, mesenteric panniculitis should be 
considered in the differential diagnosis of patients with 
severe systemic manifestations and elevated markers of the 
acute phase response of unknown etiology, especially in 
the presence of abdominal symptoms. In these cases, the 
response to steroid therapy may be excellent.
Figure 1 - Fibroadipose tissue with areas of adiponecrosis (double arrows), 
foci of mononuclear cell inflammatory infiltrate (long arrows) and prolif-
eration of bundle-forming fibroblasts (large arrow) (Hematoxylin-eosin, 
× 100)
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